PsiQuantum Targets 2027 for Photonics-Based Quantum Computer, Raises Over $1 Billion

PsiQuantum, a Silicon Valley startup, is developing a large-scale, commercially useful quantum computer based on photonics, with hardware targeted for 2027. This approach uses photons of light and aims to overcome engineering bottlenecks faced by competitors, potentially predicting drug-enzyme interactions in minutes. For broader context, explore our AI News.

A Photonics-First Approach to Quantum Computing

Unlike many competitors, PsiQuantum is developing a large-scale quantum computer based on photonics. This means their systems use photons of light to perform quantum computations. This method is designed to overcome some of the engineering bottlenecks encountered by other quantum computing architectures. By manufacturing its chips in existing semiconductor fabrication facilities, PsiQuantum aims for scalability and integration with established production processes.

The company's commitment to this approach is backed by substantial investment, having raised over $1 billion in funding. This capital supports their aggressive development schedule and the establishment of critical infrastructure.

Global Expansion and Strategic Partnerships

PsiQuantum's development efforts are geographically distributed, with the company breaking ground on a facility in Chicago and securing a second site in Australia. The Australian site is specifically targeted to be "hardware-ready" by 2027, underscoring the company's focused timeline for delivering a functional quantum computer. These strategic locations facilitate both research and manufacturing capabilities.

In a notable validation of its technology and progress, PsiQuantum and Microsoft are the only two companies to have reached stage three of a US government evaluation program for quantum firms. This achievement highlights the perceived potential and technical maturity of PsiQuantum's photonic quantum computing platform within the broader quantum landscape.

The Promise of Practical Applications

The ultimate goal of PsiQuantum's efforts is to deliver a quantum computer capable of solving real-world problems that are currently intractable for even the most powerful classical supercomputers. One compelling example cited by the company is the prediction of drug-enzyme interactions. PsiQuantum claims its machines could perform this complex task in approximately four minutes, a process that currently takes over ten years using conventional methods. Such a breakthrough would revolutionize drug discovery and development, significantly accelerating the pace of medical innovation.

This potential for dramatic acceleration in critical scientific fields underscores the "why this matters" for readers interested in the future of AI and scientific research. The ability to tackle problems of this magnitude could unlock new frontiers in materials science, finance, and artificial intelligence itself.

What to Watch Next

As PsiQuantum progresses towards its 2027 hardware readiness target, the industry will be closely watching for updates on their photonic quantum computer's development and performance benchmarks. The success of their approach could significantly influence the direction of quantum computing research and commercialization. The collaboration with existing semiconductor foundries and the strategic global facility expansion are also key indicators of their path forward.

Sources

• Do we have a quantum computer? Expert perspectives on current status and future prospects
• https://www.technologyreview.com/2026/07/14/1140356/psiquantum-plan-massive-quantum-computer-out-of-light/